Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
- 1 September 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 354 (9182), 896-900
- https://doi.org/10.1016/s0140-6736(98)11104-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- Prognostic Value of Immunohistochemically Identifiable Tumor Cells in Lymph Nodes of Patients with Completely Resected Esophageal CancerNew England Journal of Medicine, 1997
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Antigen Retrieval Immunohistochemistry: Past, Present, and FutureJournal of Histochemistry & Cytochemistry, 1997
- Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal StatusJNCI Journal of the National Cancer Institute, 1996
- Detection and significance of occult metastases in node-negative breast cancerBritish Journal of Surgery, 1993
- Micrometastases in breast cancer: Long-term follow-up of the first patient cohortEuropean Journal of Cancer and Clinical Oncology, 1991
- Prognostic factors in breast cancerSeminars in Surgical Oncology, 1989
- Occult Tumor Cells in the Lymph Nodes of Patients with Pathological Stage I Malignant Melanoma An Immunohistological StudyThe American Journal of Surgical Pathology, 1988
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983